Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03450636
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
801 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}PYRIDIN-3-OLATE | A | 1O34 | 0.7 | |
801 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}PYRIDIN-3-OLATE | A | 1O31 | 0.7 | |
801 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}PYRIDIN-3-OLATE | A | 1O33 | 0.7 | |
801 | 2-{5-[AMINO(IMINIO)METHYL]-1H-BENZIMIDAZOL- 2-YL}PYRIDIN-3-OLATE | A | 1O32 | 0.7 | |
3AA | 3-AMINOPYRIDINE-ADENINE DINUCLEOTIDE PHOSPHATE | A,B,E,F | 1F6M | 0.72 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEF | 0.75 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEG | 0.75 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,T | 2JEI | 0.75 | |
BZG | 6-(BENZYLOXY)-9-(2-DEOXY-5-O-PHOSPHONO- BETA-D-ERYTHRO-PENTOFURANOSYL)- 9H-PURIN-2-AMINE | A,P,T | 2JEJ | 0.75 | |
DOT | 3'ANTHRANILOYL-2'-DEOXY-ADENOSINE- 5'-TRIPHOSPHATE | A,B,C,D,E,F | 1LVC | 0.72 | |
S03 | 1-{4-[4-AMINO-5-(3-METHOXYPHENYL)- 7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL]BENZYL}PIPERIDIN- 4-OL | A,B | 1YOL | 0.72 | |
3GO | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- (quinolin-6-ylmethylamino)purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZM | 0.8 | |
207 | 1-AMINO-6-CYCLOHEX-3-ENYLMETHYLOXYPURINE | A | 1H0W | 0.72 | |
MBZ | 1-[2-DEOXYRIBOFURANOSYL]-4-METHYL- BENZOIMIDAZOLE-5'-MONOPHOSPHATE | 1,2 | 1EEK | 0.72 | |
DBI | PHOSPHORIC ACID MONO-[5-(5,6-DIMETHYL- BENZOIMIDAZOL-1-YL)-4-HYDROXY-2- HYDROXYMETHYL-TETRAHYDRO-FURAN- 3-YL] ESTER | A | 1ID8 | 0.72 | |
3BK | (2R,3R,4S,5R)-2-[6-amino-8-[(3,4- dichlorophenyl)methylamino]purin- 9-yl]-5-(hydroxymethyl)oxolane- 3,4-diol | A | 3FZK | 0.74 | |
FYA | ADENOSINE-5'-[PHENYLALANINOL-PHOSPHATE] | A,B | 2IY5 | 0.77 | |
FYA | ADENOSINE-5'-[PHENYLALANINOL-PHOSPHATE] | A | 1B7Y | 0.77 | |
PU6 | 8-BENZO[1,3]DIOXOL-,5-YLMETHYL- 9-BUTYL-9H- | A | 1UY9 | 0.71 | |
PUY | PUROMYCIN | A,B | 2DPT | 0.74 | |
PUY | PUROMYCIN | 1,2,4,5,A,B, C,D,E,J,K,L, M,N,O,P,R,S, T,U,V,Z | 1Q7Y | 0.74 | |
FM1 | 2-HYDROXYMETHYL-5-(7-METHYLAMINO- 3H-PYRAZOLO[4,3-D]PYRIMIDIN-3-YL)- TETRAHYDRO-FURAN-3,4-DIOL | A,B,C,D,E,F | 1K9S | 0.81 | |
PU2 | 8-(2,5-DIMETHOXY-BENZYL)-2-FLUORO- 9H-PURIN-6-YLAMINE | A | 1UYG | 0.71 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,C,D,E,F | 3E8C | 0.71 | |
G96 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(2R)-2-amino- 3-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E88 | 0.71 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 5 | 1NJP | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,2,3,4,5, 9,A,B,C,D,F, H,J,K,L,M,N, O,Q,R,S,T,U, Y,Z | 1VQN | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,3,4,9,A, B,C,D,F,H,J, K,L,M,N,O,Q, R,S,T,U,Y,Z | 1VQO | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,5 | 1NJM | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 5 | 1NJO | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,3,4,9,A, B,C,D,F,H,J, K,L,M,N,O,Q, R,S,T,U,Y,Z | 1VQL | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,2,3,4,9, A,B,C,F,H,J, K,L,M,N,O,Q, R,S,T,U,Y,Z | 1VQM | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 1,2,4,5,A,B, C,D,E,J,K,L, M,N,O,P,R,S, T,U,V,Z | 1Q82 | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,2,4,9,A,B, C,H,I,J,K,L, M,N,P,Q,R,S, T,X,Y,Z | 1KQS | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | B | 1FG0 | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 1,2,4,5,A,B, C,D,E,J,K,L, M,N,O,P,R,S, T,U,V,Z | 1Q81 | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,3,4,9,A, B,C,F,H,J,K, L,M,N,O,Q,R, S,T,U,Y,Z | 3CD6 | 0.72 | |
PPU | PUROMYCIN-5'-MONOPHOSPHATE | 0,1,3,4,9,A, B,C,D,F,H,J, K,L,M,N,O,Q, R,S,T,U,Y,Z | 1VQP | 0.72 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 2QUJ | 0.75 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6K | 0.75 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 1R6U | 0.75 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6M | 0.75 | |
TYM | TRYPTOPHANYL-5'AMP | A,B | 1R6T | 0.75 | |
TYM | TRYPTOPHANYL-5'AMP | A | 1I6L | 0.75 | |
BZ9 | N-[3-methyl-4-({3-[2-(methylamino)pyrimidin- 4-yl]pyridin-2-yl}oxy)naphthalen- 1-yl]-1H-benzimidazol-2-amine | A | 3DA6 | 0.7 | |
ALH | 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE | A,B | 1UNG | 0.77 | |
223 | (3R,4R)-1-[(4-AMINO-5H-PYRROLO[3,2- D]PYRIMIDIN-7-YL)METHYL]-4-(HYDROXYMETHYL)PYRROLIDIN- 3-OL | A,B,C,D,E,F | 2ISC | 0.82 | |
P1D | ((2S,3AS,4R,6S)-4-(HYDROXYMETHYL)- 6-(4-OXO-4,5-DIHYDRO-3H-PYRROLO[3,2- D]PYRIMIDIN-7-YL)-TETRAHYDROFURO[3,4- D][1,3]DIOXOL-2-YL)METHYLPHOSPHONIC ACID | A | 2AI2 | 0.71 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1X38 | 0.74 | |
IDD | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-PHENYL-5,6,7,8-TETRAHYDROIMIDAZO[1,2- A]PYRIDINE-6,7,8-TRIOL | A | 1LQ2 | 0.74 | |
NXX | A,B,C,D | 3DLA | 0.71 | ||
NXX | A,B,C | 2QTR | 0.71 | ||
ABS | (S)-(N-PHENYL-2-HYDROXY-ETHYL)- 2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE | A | 1K5F | 0.8 | |
LNC | (3S)-5-(3-CARBOXY-3-HYDROXYPROPYL) NICOTINAMIDE- ADENINE-DINUCLEOTIDE | A,B | 5LDH | 0.71 | |
PAD | 5-BETA-D-RIBOFURANOSYLPICOLINAMIDE ADENINE- DINUCLEOTIDE | A | 1A72 | 0.73 | |
PAD | 5-BETA-D-RIBOFURANOSYLPICOLINAMIDE ADENINE- DINUCLEOTIDE | A,B | 1ADC | 0.73 | |
MNT | 2'(3')-O-N-METHYLANTHRANILOYL-ADENOSINE- 5'-DIPHOSPHATE | A | 1LVK | 0.72 | |
R6C | (2R)-2-{[6-(BENZYLOXY)-9-ISOPROPYL- 9H-PURIN-2-YL]AMINO}BUTAN-1-OL | A | 1YHJ | 0.71 | |
DF9 | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2- d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin- 3-ol | A,B | 3DF9 | 0.75 | |
TAP | 7-THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | A | 1DR2 | 0.73 | |
TAP | 7-THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | A | 1DR3 | 0.73 | |
TAP | 7-THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | A,B | 1PT9 | 0.73 | |
PU7 | 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)- 9H-PURIN-6-YLAMINE | A | 1UYC | 0.72 | |
NBS | A | 1KSW | 0.76 | ||
DF1 | (2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3- D]PYRIMIDIN-4-YL)AMINO]PROPAN-2- OL | A | 2BRN | 0.7 | |
PU3 | 9-BUTYL-8-(3,4,5-TRIMETHOXYBENZYL)- 9H-PURIN-6-AMINE | A | 1UYM | 0.72 | |
PU3 | 9-BUTYL-8-(3,4,5-TRIMETHOXYBENZYL)- 9H-PURIN-6-AMINE | A | 1UY6 | 0.72 | |
AD3 | 3-DEAZA-ADENOSINE | A,B | 1KIE | 0.78 | |
AD3 | 3-DEAZA-ADENOSINE | A,B,C,D | 2ZIZ | 0.78 | |
AD3 | 3-DEAZA-ADENOSINE | A,B | 1R4F | 0.78 | |
AD3 | 3-DEAZA-ADENOSINE | A,B | 1HP0 | 0.78 | |
BIG | (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2- d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin- 3-ol | A,C | 3DP9 | 0.75 | |
SND | THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B,C,D | 1IHX | 0.73 | |
SND | THIONICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B,C | 1PTJ | 0.73 | |
NHV | (5R,6R,7S,8R)-6,7,8-trihydroxy- 5-(hydroxymethyl)-2-[(phenylamino)methyl]- 5,6,7,8-tetrahydro-1H-imidazo[1,2- a]pyridin-4-ium | A,B | 2VOT | 0.72 | |
XAE | 3-(2-DEOXY-5-O-PHOSPHONO-BETA-D- ERYTHRO-PENTOFURANOSYL)-3H-IMIDAZO[4,5- G]QUINAZOLIN-8-AMINE | A,B | 2ICZ | 0.74 | |
JMQ | (2R,3R,4S)-2-(hydroxymethyl)-1- [(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin- 7-yl)methyl]pyrrolidine-3,4-diol | A,B | 3EPW | 0.81 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A | 1J1S | 0.78 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A,B,C,D,E,F | 1T8S | 0.78 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A | 1FMP | 0.78 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A | 1AHB | 0.78 | |
FMP | FORMYCIN-5'-MONOPHOSPHATE | A,B | 1PAG | 0.78 | |
PU5 | 9-BUTYL-8-(3-METHOXYBENZYL)-9H- PURIN-6-AMINE | A | 1UY8 | 0.72 | |
1DA | 1-DEAZA-ADENOSINE | A | 1ADD | 0.77 | |
ANZ | A | 2V0C | 0.73 | ||
ANZ | A,B,D,F | 2V0G | 0.73 | ||
PU0 | 9-BUTYL-8-(2,5-DIMETHOXY-BENZYL)- 2-FLUORO-9H-PURIN-6-YLAMINE | A | 1UYH | 0.7 | |
TYA | A | 3TS1 | 0.76 | ||
CND | 5-BETA-D-RIBOFURANOSYLNICOTINAMIDE ADENINE DINUCLEOTIDE | A,B | 1ADB | 0.79 | |
MTM | (3S,4R)-2-(4-AMINO-5H-PYRROLO[3,2- D]PYRIMIDIN-7-YL)-5-[(METHYLSULFANYL)METHYL]PYRROLIDINE- 3,4-DIOL | A,B,C,D,E,F | 1ZOS | 0.74 | |
MTM | (3S,4R)-2-(4-AMINO-5H-PYRROLO[3,2- D]PYRIMIDIN-7-YL)-5-[(METHYLSULFANYL)METHYL]PYRROLIDINE- 3,4-DIOL | A,B | 1Y6R | 0.74 | |
MTM | (3S,4R)-2-(4-AMINO-5H-PYRROLO[3,2- D]PYRIMIDIN-7-YL)-5-[(METHYLSULFANYL)METHYL]PYRROLIDINE- 3,4-DIOL | A | 1K27 | 0.74 | |
HET | 3-[2-(2-CYCLOPENTYL-6-{[4-(DIMETHYLPHOSPHORYL)PHENYL]AMINO}- 9H-PURIN-9-YL)ETHYL]PHENOL | A | 2BDJ | 0.71 | |
RBZ | ALPHA-RIBAZOLE-5'-PHOSPHATE | A | 1D0V | 0.72 | |
RBZ | ALPHA-RIBAZOLE-5'-PHOSPHATE | A | 1L4E | 0.72 | |
PGI | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-(2-PHENYLETHYL)-1,5,6,7,8,8A- HEXAHYDROIMIDAZO[1,2-A]PYRIDINE- 6,7,8-TRIOL | A,B | 2CET | 0.71 | |
PGI | (5R,6R,7S,8S)-5-(HYDROXYMETHYL)- 2-(2-PHENYLETHYL)-1,5,6,7,8,8A- HEXAHYDROIMIDAZO[1,2-A]PYRIDINE- 6,7,8-TRIOL | A,B | 2CER | 0.71 | |
N20 | 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE | A,B,C,D | 1OI9 | 0.7 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 2OC9 | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 1B8O | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B,C | 1G2O | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B,C,D,E,F | 1NW4 | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 1RT9 | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B | 2FF1 | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B | 2FF2 | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 2OC4 | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | E | 2Q7O | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 1RR6 | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A,B | 3B9G | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | E | 1PF7 | 0.85 | |
IMH | 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN- 9-YL)-D-RIBITOL | A | 2ON6 | 0.85 | |
ONA | A,C | 2GVZ | 0.74 | ||
ZZB | A | 2WFG | 0.75 | ||
WSA | 5'-O-[(L-TRYPTOPHYLAMINO)SULFONYL]ADENOSINE | A,B,C,D | 2YY5 | 0.75 | |
NBD | N6-BENZYL-NICOTINAMIDE-ADENINE- DINUCLEOTIDE | A,B,C,D | 1GYQ | 0.71 | |
IMG | 1,4-DIDEOXY-1,4-IMINO-1-(S)-(9- DEAZAGUANIN-9-YL)-D-RIBITOL | A,B | 1DQP | 0.71 | |
IMG | 1,4-DIDEOXY-1,4-IMINO-1-(S)-(9- DEAZAGUANIN-9-YL)-D-RIBITOL | A | 1B8N | 0.71 | |
MHR | 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin- 3-yl)pyrimidin-2-amine | A,B,C,D | 3BHU | 0.73 | |
TDI | (3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2- D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN- 3-OL | A,B | 1Y6Q | 0.76 | |
ABR | (R)-(N-PHENYL-2-HYDROXY-ETHYL)- 2'-DEOXY-ADENOSINE-5'-MONOPHOSPHATE | A | 1K5E | 0.8 | |
43P | 4-(1H-IMIDAZOL-4-YL)-3-(5-ETHYL- 2,4-DIHYDROXY-PHENYL)-1H-PYRAZOLE | A | 1YC4 | 0.72 | |
IDE | (5R,6R,7S,8S)-3-(ANILINOMETHYL)- 5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)- IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | A | 1X39 | 0.71 | |
IDE | (5R,6R,7S,8S)-3-(ANILINOMETHYL)- 5,6,7,8-TETRAHYDRO-5-(HYDROXYMETHYL)- IMIDAZO[1,2-A]PYRIDINE-6,7,8-TRIOL | A,B | 2J7C | 0.71 | |
IMK | 2-(BETA-D-GLUCOPYRANOSYL)-5-METHYL- 1-BENZIMIDAZOLE | A | 1XKX | 0.74 | |
121 | 2-(3-HYDROXY-PYRIDIN-2-YL)-1H-BENZOIMIDAZOLE- 5-CARBOXAMIDINE | H,I,L | 1GHY | 0.71 | |
1HP | 4-(2-amino-1-methyl-1H-imidazo[4,5- b]pyridin-6-yl)phenol | A,B | 2QSE | 0.73 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B,E,I,L,P | 3E8E | 0.73 | |
G98 | 4-[2-(4-amino-2,5-dihydro-1,2,5- oxadiazol-3-yl)-6-{[(1S)-3-amino- 1-phenylpropyl]oxy}-1-ethyl-1H- imidazo[4,5-c]pyridin-4-yl]-2-methylbut- 3-en-2-ol | A,B | 3E8D | 0.73 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KQO | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H29 | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1NUQ | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1WXG | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D,E,F | 1KAQ | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1EE1 | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B,C,D | 3E27 | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A | 1XQD | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 2H2A | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1IFX | 0.71 | |
DND | NICOTINIC ACID ADENINE DINUCLEOTIDE | A,B | 1XNG | 0.71 | |
FA5 | ADENOSINE-5'-[PHENYLALANINYL-PHOSPHATE] | A | 3CMQ | 0.73 | |
FA5 | ADENOSINE-5'-[PHENYLALANINYL-PHOSPHATE] | A,B | 1JJC | 0.73 | |
GVI | N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE | A | 2UVY | 0.71 | |
RMB | N1-(5'-PHOSPHO-ALPHA-RIBOSYL)-5- METHYLBENZIMIDAZOLE | A | 1JHO | 0.72 | |
IGP | INDOLE-3-GLYCEROL PHOSPHATE | A | 1A53 | 0.71 | |
IGP | INDOLE-3-GLYCEROL PHOSPHATE | A,B | 2RHG | 0.71 | |
IGP | INDOLE-3-GLYCEROL PHOSPHATE | A,B | 1KFB | 0.71 | |
IGP | INDOLE-3-GLYCEROL PHOSPHATE | A,B | 2RH9 | 0.71 | |
IGP | INDOLE-3-GLYCEROL PHOSPHATE | A,B | 1A5B | 0.71 | |
IGP | INDOLE-3-GLYCEROL PHOSPHATE | A,B | 1QOQ | 0.71 | |
NDA | 3-AMINOMETHYL-PYRIDINIUM-ADENINE- DINUCLEOTIDE | A,B,C,D | 1EBU | 0.75 | |
UA2 | 3,4-PYRROLIDINEDIOL,2-(4-AMINO- 5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)- 5-(HYDROXYMETHYL)-2S,3S,4R,5R | A,B,C | 2I4T | 0.91 | |
HDY | 1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2- A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN- 2-OL | A | 1OIR | 0.71 | |
CK9 | 2-{[(2-{[(1R)-1-(HYDROXYMETHYL)PROPYL]AMINO}- 9-ISOPROPYL-9H-PURIN-6-YL)AMINO]METHYL}PHENOL | X | 2A0C | 0.72 | |
CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B | 1SZC | 0.71 | |
CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A | 1A26 | 0.71 | |
CNA | CARBA-NICOTINAMIDE-ADENINE-DINUCLEOTIDE | A,B | 2OD2 | 0.71 | |
RC8 | (2R)-2-({9-(1-methylethyl)-6-[(4- pyridin-2-ylbenzyl)amino]-9H-purin- 2-yl}amino)butan-1-ol | A,C | 3DDP | 0.72 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 2ALY | 0.73 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 1VBM | 0.73 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 1VBN | 0.73 | |
YSA | 5'-O-[N-(L-TYROSYL)SULFAMOYL]ADENOSINE | A,B | 2PID | 0.73 | |
3FD | 4-[[(2R,3S,4R,5R)-5-[6-amino-8- [(3,4-dichlorophenyl)methylamino]purin- 9-yl]-3,4-dihydroxy-oxolan-2-yl]methoxymethyl]benzonitrile | A | 3FZL | 0.76 | |
DF2 | (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7- DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN- 4-YLIDENE]AMINO}PROPANE-1,2-DIOL | A | 2BRO | 0.73 | |
YMP | O-(ADENOSINE-5'-O-YL)-N-(L-TYROSYL)PHOSPHORAMIDATE | X,Y | 2DLC | 0.72 | |
FMC | FORMYCIN | A,B | 2QTT | 0.81 | |
FMC | FORMYCIN | A | 1MRH | 0.81 | |
FMC | FORMYCIN | A | 1SD1 | 0.81 | |
FMC | FORMYCIN | A | 1MRK | 0.81 | |
FMC | FORMYCIN | A,B | 1NC3 | 0.81 | |
FMC | FORMYCIN | A | 1Z36 | 0.81 | |
FMC | FORMYCIN | A | 3BL6 | 0.81 | |
FMC | FORMYCIN | A | 1IFU | 0.81 | |
C4F | 3-(3-methoxybenzyl)-1H-pyrrolo[2,3- b]pyridine | A,B | 3C4F | 0.7 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A | 2BGM | 0.71 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1N8K | 0.71 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A | 2BGL | 0.71 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1N92 | 0.71 | |
NAJ | NICOTINAMIDE-ADENINE-DINUCLEOTIDE (ACIDIC FORM) | A,B | 1H2B | 0.71 | |
1BM | 3-{[2-(1H-BENZIMIDAZOL-1-YL)-6- {[2-(DIETHYLAMINO)ETHYL]AMINO}PYRIMIDIN- 4-YL]AMINO}-4-METHYLPHENOL | A | 2HK5 | 0.72 | |
9DI | 9-DEAZAINOSINE | A | 1A9P | 0.77 | |
MFR | 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin- 3-yl)pyrimidin-2-amine | A,B,C,D | 3BHT | 0.73 | |
VGB | (5R,6R,7R,8S)-6,7-dihydroxy-5-(hydroxymethyl)- 2-(2-phenylethyl)-8-(propanoylamino)- 5,6,7,8-tetrahydro-1H-imidazo[1,2- a]pyridin-4-ium | A,B | 2WB5 | 0.7 | |
FM2 | 2-(7-AMINO-6-METHYL-3H-PYRAZOLO[4,3- D]PYRIMIDIN-3-YL)-5-HYDROXYMETHYL- TETRAHYDRO-FURAN-3,4-DIOL | A,B,C,D,E,F | 1K9S | 0.79 |